First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...

Recurrent urinary tract infection (RUTI) can damage renal function and has impact on healthcare costs and patients’ quality of life. There were 2 stages for development of prediction models for RUTI.

GSK wins FDA approval for Utebzi, the first oral carbapenem for complicated UTIs, further expanding its anti-infectives ...

Urinary tract infections (UTIs) are a persistent and deadly global health problem and a considerable cause of health-care resource utilization. In 2019, an estimated 405 million infections and 267,000 ...

Spero Therapeutics (NASDAQ:SPRO) shares climbed 16% on Thursday after the U.S. Food and Drug Administration approved Utebzi, ...

FDA approved Utebzi, an oral carbapenem antibiotic developed by GSK in partnership with Spero Therapeutics, for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis in ...

Gaffin is an infectious disease physician in New Jersey. Recently, a former patient contacted me about his wife. “She had a recent stroke which has caused cognitive decline along with slow-growing ...

Urinary tract infections (UTIs) commonly occur in people who undergo chemotherapy. The treatment can weaken the immune system and damage barriers, such as the skin and mucous membranes, that help ...

Children often contract bacterial infections, with urinary tract infections (UTIs) being one of the most common types.

Lower urinary tract symptoms are common and occur for a variety of reasons, from physical obstructions to excessive caffeine consumption. Treatment will depend on what’s causing your symptoms.

UTIs may cause neurological symptoms, especially in older adults. It can also worsen symptoms in people with neurological conditions. Diagnosing and treating the UTI may help prevent serious ...